![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 11
2022
Heres, Stephan; Cordes, Joachim; Feyerabend, Sandra; Schmidt-Kraepelin, Christian; Musil, Richard; Riedel, Michael; Spellmann, Ilja; Langguth, Berthold; Landgrebe, Michael; Fran, Elmar; Petcu, Camelia C.; Hahn, Eric; Ta, Tam M. T.; Matei, Valentin; Dehelean, Liana; Papava, Ion; Leweke, F. Markus; List, Till van der; Tamasan, Simona C.; Lang, Fabian U.; Naber, Dieter; Ruhrmann, Stephan; Wolff-Menzler, Claus; Juckel, Georg; Ladea, Maria; Stefanescu, Cristinel; Lautenschlager, Marion; Bauer, Michael; Zamora, Daisy; Horowitz, Mark; Davis, John M. und Leucht, Stefan
(2022):
Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine: Randomized, Double-Blind Trial in Patients With Schizophrenia.
In: Schizophrenia Bulletin, Bd. 48, Nr. 6: S. 1273-1283
2020
Kirchner, Sophie K.; Ozkan, Selen; Musil, Richard; Spellmann, Ilja; Kannayian, Nirmal; Falkai, Peter; Rossner, Moritz und Papiol, Sergi
(2020):
Polygenic analysis suggests the involvement of calcium signaling in executive function in schizophrenia patients.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 270, Nr. 4: S. 425-431
Schennach, Rebecca; Riedel, Michael; Obermeier, Michael; Jaeger, Markus; Schmauss, Max; Laux, Gerd; Pfeiffer, Herbert; Naber, Dieter; Schmidt, Lutz G.; Gaebel, Wolfgang; Klosterkoetter, Joachim; Heuser, Isabella; Maier, Wolfgang; Lemke, Matthias R.; Ruether, Eckart; Klingberg, Stefan; Gastpar, Markus; Seemueller, Florian; Spellmann, Ilja; Musil, Richard und Moeller, Hans-Jürgen
(2020):
What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a "real-world" 2-year follow-up trial.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 270, Nr. 6: S. 661-671
2019
Schennach, Rebecca; Riedel, Michael; Spellmann, Ilja; Musil, Richard; Obermeier, Michael; Jaeger, Markus; Bottlender, Roland; Schmauss, Max; Laux, Gerd und Moeller, Hans-Jürgen
(2019):
Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study.
In: Pharmacopsychiatry, Bd. 52, Nr. 4: S. 180-185
Schennach, Rebecca; Obermeier, Michael; Spellmann, Ilja; Seemüller, Florian; Musil, Richard; Jaeger, Markus; Schmauss, Max; Laux, Gerd; Pfeiffer, Herbert; Naber, Dieter; Schmidt, Lutz G.; Gaebel, Wolfgang; Klosterkoetter, Joachim; Heuser, Isabella; Bauer, Michael; Adli, Mazda; Zeiler, Joachim; Bender, Wolfram; Kronmüller, Klaus-Thomas; Ising, Marcus; Brieger, Peter; Maier, Wolfgang; Lemke, Matthias R.; Ruether, Eckart; Klingberg, Stefan; Gastpar, Markus; Moeller, Hans-Jürgen und Riedel, Michael
(2019):
Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression.
In: Schizophrenia Research, Bd. 209: S. 185-192
2018
Musil, Richard; Seemüller, Florian; Meyer, Sebastian; Spellmann, Ilja; Adli, Mazda; Bauer, Michael; Kronmüller, Klaus-Thomas; Brieger, Peter; Laux, Gerd; Bender, Wolfram; Heuser, Isabella; Fisher, Robert; Gäbel, Wolfgang; Schennach, Rebecca; Möller, Hans-Jürgen und Riedel, Michael
(2018):
Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder.
In: International Journal of Methods in Psychiatric Research, Bd. 27, Nr. 1, e1569
Spellmann, Ilja; Reinhard, Matthias A.; Veverka, Diana; Zill, Peter; Obermeier, Michael; Dehning, Sandra; Schennach, Rebecca; Müller, Norbert; Möller, Hans-Jürgen; Riedel, Michael und Musil, Richard
(2018):
QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 268, Nr. 4: S. 383-390
2017
Spellmann, Ilja; Schennach, Rebecca; Seemüller, Florian; Meyer, Sebastian; Musil, Richard; Jäger, Markus; Schmauß, Max; Laux, Gerd; Pfeiffer, Herbert; Naber, Dieter; Schmidt, Lutz G.; Gaebel, Wolfgang; Klosterkötter, Joachim; Heuser, Isabella; Bauer, Michael; Adli, Mazda; Zeiler, Joachim; Bender, Wolfram; Kronmüller, Klaus-Thomas; Ising, Marcus; Brieger, Peter; Maier, Wolfgang; Lemke, Matthias R.; Rüther, Eckart; Klingberg, Stefan; Gastpar, Markus; Riedel, Michael und Möller, Hans-Jürgen
(2017):
Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 267, Nr. 4: S. 303-313
Schennach, Rebecca; Obermeier, Michael; Seemüller, Florian; Jäger, Markus; Schmauss, Max; Laux, Gerd; Pfeiffer, Herbert; Naber, Dieter; Schmidt, Lutz G.; Gäbel, Wolfgang; Klosterköter, Joachim; Heuser, Isabella; Maier, Wolfgang; Lemke, Matthias R.; Rüther, Eckart; Klingberg, Stefan; Gastpar, Markus; Spellmann, Ilja; Musil, Richard; Möller, Hans-Jürgen und Riedel, Michael
(2017):
Add-on Antidepressants in the Naturalistic Treatment of - Schizophrenia Spectrum Disorder - When, Who, and How?
In: Pharmacopsychiatry, Bd. 50, Nr. 4: S. 136-144
Spellmann, Ilja; Riedel, Michael; Städtler, Julia; Zill, Peter; Obermeier, Michael; Cerovecki, Anja; Dehning, Sandra; Schennach, Rebecca; Epple, Maria; Opgen-Rhein, Markus; Müller, Norbert; Bondy, Brigitta; Möller, Hans-Jürgen und Musil, Richard
(2017):
Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment.
In: Cognitive Neuropsychiatry, Bd. 22, Nr. 4: S. 280-297
2016
Schennach, Rebecca; Möller, Hans-Jürgen; Obermeier, Michael; Seemüller, Florian; Jäger, Markus; Schmauss, Max; Laux, Gerd; Pfeiffer, Herbert; Naber, Dieter; Schmidt, Lutz G.; Gaebel, Wolfgang; Klosterkötter, Joachim; Heuser, Isabella; Maier, Wolfgang; Lemke, Matthias R.; Rüther, Eckart; Klingberg, Stefan; Gastpar, Markus; Musil, Richard; Spellmann, Ilja und Riedel, Michael
(2016):
Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methods.
In: International Journal of Methods In Psychiatric Research, Bd. 25, Nr. 1: S. 3-11